New Zealand markets close in 3 hours 22 minutes

Checkpoint Therapeutics, Inc. (CKPT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.9400+0.0500 (+2.65%)
At close: 04:00PM EDT
1.9500 +0.01 (+0.52%)
After hours: 05:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 71.49M
Enterprise value 60.25M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)685.79
Price/book (mrq)N/A
Enterprise value/revenue 886.01
Enterprise value/EBITDA -0.54

Trading information

Stock price history

Beta (5Y monthly) 1.13
52-week change 3-32.17%
S&P500 52-week change 323.23%
52-week high 33.6200
52-week low 31.3000
50-day moving average 31.7180
200-day moving average 31.9640

Share statistics

Avg vol (3-month) 3368.36k
Avg vol (10-day) 3215.35k
Shares outstanding 536.15M
Implied shares outstanding 636.85M
Float 826.48M
% held by insiders 118.83%
% held by institutions 116.12%
Shares short (15 May 2024) 43.97M
Short ratio (15 May 2024) 410.43
Short % of float (15 May 2024) 411.87%
Short % of shares outstanding (15 May 2024) 410.77%
Shares short (prior month 15 Apr 2024) 43.78M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 306 Dec 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-66,195.59%

Management effectiveness

Return on assets (ttm)-314.85%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)68k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-52.32M
Diluted EPS (ttm)-2.6100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)11.24M
Total cash per share (mrq)0.31
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)0.54
Book value per share (mrq)-0.29

Cash flow statement

Operating cash flow (ttm)-40.03M
Levered free cash flow (ttm)-31.03M